Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The 10 most talked-about journal articles about Alzheimer’s Disease

Posted on August 2nd, 2016 by in Pharma R&D

The Alzheimer’s Association International Conference just wrapped up in Toronto, Canada (Patrick May was there and will be writing all about it). In honor of the conference, here is a list of Alzheimer’s-related journal articles that were most-talked about in the last month in social media, blogs, and news coverage. Continue reading “The 10 most talked-about journal articles about Alzheimer’s Disease” »

A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2

Posted on July 18th, 2016 by in Pharma R&D

As referenced in my last post, the Drug Information Association (DIA), held its annual conference in Philadelphia at the end of June with this year’s theme being “A Gathering of Global Perspectives.” In follow-up to that post, I want to share with you what I gleaned from two additional noteworthy sessions. Continue reading “A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2” »

Reducing the Risk of Late-Stage Failure with In Silico Modeling

Posted on June 15th, 2016 by in Pharma R&D

In silico modeling is arguably one of the hottest trends in life sciences R&D today. We know that bringing drug discovery to the desktop impacts cost. Continue reading “Reducing the Risk of Late-Stage Failure with In Silico Modeling” »

Building models for rare diseases

Posted on June 2nd, 2016 by in Pharma R&D

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment Continue reading “Building models for rare diseases” »

  1. 1
  2. 2